In this study, we further explored the potential therapeutic effect of IL-17A-neutralizing monoclonal antibody (mAb) on the neurological outcome of mice with ischemic stroke and its underlying molecular mechanism of neuronal apoptosis. This evidence concerns the gene IL17A and ischemic stroke.